HIF1A and pulmonary arterial hypertension: HIF-1α, which is usually upregulated under hypoxia, was activated in PAH and led to the inhibition of miR-223-3p in PASMCs of PAH patients, resulting in upregulation of multiple miR-223-3p targets and the development of PAH (167–169).